Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR+22.3%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+22.3%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202534.04%
2024-336.97%
202364.16%
202218.63%
2021-300.00%
20200.00%
20190.00%